The International Nutrition Company, a Netherlands-based group of nutritional supplement suppliers, says that new research, reported at the International Conference on Polyphenols and Health in Kyoto, Japan, indicates that Masquelier's Original OPC antioxidant has broad therapeutic benefits. Specifically, the study found that oligomeric proanthocyanidins present in the product significantly prolong the lag phase of low-density lipoprotein oxidation, that is the period before LDL becomes oxidized and more likely to form the plaques associated with cardiovascular disease.
Oxidation a key factor in "bad" LDL
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze